BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2975904)

  • 1. Granulocyte activating factor released from Propionibacterium acnes. A possible mediator of inflammation in acne vulgaris.
    Pulverer G; Roszkowski W; Beuth HJ; Ko HL; Quie P
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):246-51. PubMed ID: 2975904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetracycline and 13-cis-retinoic acid inhibit production and activity of granulocyte activating factor (GAF) from Propionibacterium acnes.
    Pulverer G; Ko HL; Beuth J; Roszkowski W
    Zentralbl Bakteriol; 1990 Aug; 273(3):362-8. PubMed ID: 1698375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum.
    Webster GF; Leyden JJ; Norman ME; Nilsson UR
    Infect Immun; 1978 Nov; 22(2):523-9. PubMed ID: 153333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Propionibacterium acnes polypeptides which have stimulated an immune response in acne patients but not in normal individuals.
    Holland KT; Holland DB; Cunliffe WJ; Cutcliffe AG
    Exp Dermatol; 1993 Feb; 2(1):12-6. PubMed ID: 8156165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Differentiation of various Propionibacterium species from acne-vulgaris efflorescences].
    Lentze I; Ko HL; Höffler U
    Hautarzt; 1979 May; 30(5):242-7. PubMed ID: 156167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different strains of Propionibacterium acnes modulate differently the cutaneous innate immunity.
    Jasson F; Nagy I; Knol AC; Zuliani T; Khammari A; Dréno B
    Exp Dermatol; 2013 Sep; 22(9):587-92. PubMed ID: 23947673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotaxin production by comedonal bacteria (Propionibacterium acnes, Propionibacterium granulosum and Staphylococcus epidermidis).
    Puhvel SM; Sakamoto M
    J Invest Dermatol; 1980 Jan; 74(1):36-9. PubMed ID: 6444322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is acne caused by colonization with the "wrong" strain of Propionibacterium acnes? A review of the role of Propionibacterium acnes in acne].
    Lomholt HB; Kilian M
    Ugeskr Laeger; 2008 Apr; 170(15):1234-7. PubMed ID: 18433578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Physiopathological mechanisms in acne vulgaris].
    Vignale RA; Lasalvia E; Assandri J
    Med Cutan Ibero Lat Am; 1981; 9(2):79-86. PubMed ID: 6457226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory acne represents hypersensitivity to Propionibacterium acnes.
    Webster GF
    Dermatology; 1998; 196(1):80-1. PubMed ID: 9557234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and lipolytic activity of Propionibacterium acnes (Corynebacterium acnes group I) and P. granulosum (C. acnes group II) in acne and in normal skin.
    Whiteside JA; Voss JG
    J Invest Dermatol; 1973 Feb; 60(2):94-7. PubMed ID: 4266325
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed skin test reactivity to Propionibacterium acnes correlates with severity of inflammation in acne vulgaris.
    Kersey P; Sussman M; Dahl M
    Br J Dermatol; 1980 Dec; 103(6):651-5. PubMed ID: 6450605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The aetiopathogenesis of acne vulgaris - what's new?
    Bergler-Czop B
    Int J Cosmet Sci; 2014 Jun; 36(3):187-94. PubMed ID: 24575836
    [No Abstract]   [Full Text] [Related]  

  • 14. [Skin reactions to antigens of propionibacterium acnes in patients with acne vulgaris treated with autovaccine].
    Załuga E
    Ann Acad Med Stetin; 1998; 44():65-85. PubMed ID: 9857532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propionibacterium acnes in the pathogenesis and immunotherapy of acne vulgaris.
    Liu PF; Hsieh YD; Lin YC; Two A; Shu CW; Huang CM
    Curr Drug Metab; 2015; 16(4):245-54. PubMed ID: 26264195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotactic efficiency of various chemoattractants for polymorphonuclear leukocytes in inflammatory acne vulgaris.
    Knop J; Bossecker T; Kövary PM
    Arch Dermatol Res; 1982; 274(3-4):267-75. PubMed ID: 6219635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Propionibacterium acnes in the pathogenesis of acne.
    Gun JD
    Int J Dermatol; 1981 Apr; 20(3):172-3. PubMed ID: 6456241
    [No Abstract]   [Full Text] [Related]  

  • 18. Does inflammatory acne result from imbalance in the keratinocyte innate immune response?
    Grange PA; Weill B; Dupin N; Batteux F
    Microbes Infect; 2010 Dec; 12(14-15):1085-90. PubMed ID: 20691803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antimicrobial effect of CEN1HC-Br against Propionibacterium acnes and its therapeutic and anti-inflammatory effects on acne vulgaris.
    Han R; Blencke HM; Cheng H; Li C
    Peptides; 2018 Jan; 99():36-43. PubMed ID: 29108811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of toll-like receptors by Propionibacterium acnes.
    Jugeau S; Tenaud I; Knol AC; Jarrousse V; Quereux G; Khammari A; Dreno B
    Br J Dermatol; 2005 Dec; 153(6):1105-13. PubMed ID: 16307644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.